Robust pellet

Details for Australian Patent Application No. 2004264939 (hide)

Owner Advancis Pharmaceutical Corporation

Inventors Wassink, Sandra E.; Cao, Bruce X.; Baker, Matt R.; Burnside, Beth A.

Agent Spruson & Ferguson

Pub. Number AU-A-2004264939

PCT Pub. Number WO2005/016311

Priority 60/494,155 11.08.03 US

Filing date 11 August 2004

Wipo publication date 24 February 2005

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/016311 Priority application(s): WO2005/016311

2 April 2009 Alteration of Name

  The name of the applicant has been altered to MiddleBrook Pharmaceuticals, Inc.

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004264941-Pharmaceutical metered dose inhaler and methods relating thereto

2004264937-Quinazoline analogs as receptor tyrosine kinase inhibitors